Clinical trials
Phase 3 Shock trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2012 | 1 |
| 2020 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 3 |
| Completed | 2 |
| Not yet recruiting | 1 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Arginox Pharmaceuticals | 1 |
| Clinical Evaluation Research Unit at Kingston General Hospital | 1 |
| The University of Texas Health Science Center, Houston | 1 |
| University of British Columbia | 1 |
| University of Versailles | 1 |
| University of Washington | 1 |
| Western University, Canada | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shock | 7 |
| Sepsis | 2 |
| Wounds and Injuries | 2 |
| Acute Kidney Injury | 1 |
| COVID-19 | 1 |
| Coronavirus Infections | 1 |
| Critical Illness | 1 |
| Hemorrhage | 1 |
| Hemostatic Disorders | 1 |
| Hyperemia | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.